Skip to content

Feasibility Study of Introducing Virtual Reality in Breast Evaluation

Feasibility Study of Introducing Virtual Reality to Reduce Anxiety and Pain during Breast Evaluation

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042250156
Enrollment
50
Registered
2026-01-07
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Disease, Breast Neoplasms Breast Diseases, Breast Neoplasms

Interventions

During the breast biopsy (Cohort A: vacuum-assisted biopsy or Cohort B: core needle biopsy), participants will wear a VR headset and watch VR videos throughout the procedure.
D000076142, D062005
Virtual Reality, Biopsy Large-Core Needle

Sponsors

Isogai Ayaka
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older. 2. Female patients. 3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. 4. Presence of a breast tumor requiring a needle biopsy to be performed under ultrasound guidance. 5. Ability to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients scheduled to undergo a tissue biopsy of the axilla. 2. Patients scheduled to undergo fine-needle aspiration (FNA) or cytology of the breast or axilla on the same day as the tissue biopsy. 3. Patients with a history of breast surgery. 4. Patients with a history of breast tissue biopsy. 5. Patients who are currently pregnant or breastfeeding. 6. Patients deemed to have limitations in vision, hearing, or cognition that may affect participation in this study. 7. Patients with a history of epilepsy, or those who have experienced loss of consciousness or epilepsy-related symptoms in the past. 8. Patients currently taking (including as-needed use) antidepressants, anxiolytics, or antiepileptic medications. 9. Patients considered to have claustrophobia. 10. Patients using implantable medical devices such as cardiac pacemakers or defibrillators, or those who require the use of a hearing aid during the examination. 11. Patients with suspected infectious symptoms or communicable diseases, particularly eye infections (e.g., conjunctivitis), or skin/scalp conditions. 12. Patients judged to lack the ability to understand the content of the informed consent document. 13. Patients deemed inappropriate for participation in the study by the principal investigator or sub-investigator. 14. Patients who requested a prior virtual reality (VR) experience and, based on the experience, were considered unable to participate in the study. (If patients did not request the prior VR experience, it may be omitted.)

Design outcomes

Primary

MeasureTime frame
The feasibility of using VR during biopsy

Secondary

MeasureTime frame
Change in pain level before and after the procedure, Change in anxiety level before and after the procedure, Amount of local anesthetic used, Time taken to acclimate to VR after viewing begins, Tolerability of wearing the VR headset, Success rate of the biopsy

Contacts

Public ContactAyaka Isogai

Nagoya City University Hospital

a.isogai@med.nagoya-cu.ac.jp+81-52-853-8336

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026